News Detail
Washington, 21 March 2022: AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study.
......
View Details
Source : Livemint
Related News
- Researchers resolve old mystery of how phages disarm pathogenic bacteria (16-04-2024)
- Carbon beads help restore healthy gut microbiome and reduce liver disease progression (15-04-2024)
- New microfluidic device improves the separation of tumor cells and clusters from malignant effusions (15-04-2024)
- AI makes retinal imaging 100 times faster than manual method (14-04-2024)
- Beta-blockers show no benefit for heart attack patients with normal heart function (11-04-2024)
- GLP-1 analogs not linked to thyroid cancer risk, study finds (11-04-2024)
- Post-surgery infections may mainly be caused by skin bacteria (11-04-2024)
- Many cancer drugs remain unproven 5 yrs after accelerated app (08-04-2024)
- Gut bacteria linked to younger colon cancer patients (08-04-2024)
- Researchers create new tool for assessing risk of kidney injury after chemotherapy (29-03-2024)